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Abstract: The ongoing coronavirus disease 2019 (COVID-19) pandemic emphasizes the need to
actively study the virome of unexplained respiratory diseases. We performed viral metagenomic
next-generation sequencing (mNGS) analysis of 91 nasal-throat swabs from individuals working
with animals and with acute respiratory diseases. Fifteen virus RT-PCR-positive samples were
included as controls, while the other 76 samples were RT-PCR negative for a wide panel of respiratory
pathogens. Eukaryotic viruses detected by mNGS were then screened by PCR (using primers based
on mNGS-derived contigs) in all samples to compare viral detection by mNGS versus PCR and
assess the utility of mNGS in routine diagnostics. mNGS identified expected human rhinoviruses,
enteroviruses, influenza A virus, coronavirus OC43, and respiratory syncytial virus (RSV) A in 13 of 15
(86.7%) positive control samples. Additionally, rotavirus, torque teno virus, human papillomavirus,
human betaherpesvirus 7, cyclovirus, vientovirus, gemycircularvirus, and statovirus were identified
through mNGS. Notably, complete genomes of novel cyclovirus, gemycircularvirus, and statovirus
were genetically characterized. Using PCR screening, the novel cyclovirus was additionally detected
in 5 and the novel gemycircularvirus in 12 of the remaining samples included for mNGS analysis.
Our studies therefore provide pioneering data of the virome of acute-respiratory diseases from
individuals at risk of zoonotic infections. The mNGS protocol/pipeline applied here is sensitive for
the detection of a variety of viruses, including novel ones. More frequent detections of the novel
viruses by PCR than by mNGS on the same samples suggests that PCR remains the most sensitive
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diagnostic test for viruses whose genomes are known. The detection of novel viruses expands our
understanding of the respiratory virome of animal-exposed humans and warrant further studies.
Keywords: virome; acute respiratory disease; NGS; metagenomics; zoonoses; novel cyclovirus; novel
statovirus; novel gemycircularvirus
1. Introduction
Acute respiratory infections are the leading cause of morbidity and mortality worldwide [1,2].
Despite intensive laboratory investigations, a substantial proportion of acute respiratory infections
are of unknown etiology, resulting in difficulties in clinical management [3–6]. Metagenomics is an
unbiased (independent of specific sequences) approach increasingly being applied in virus discovery
as well as for molecular diagnostics [6–8].
Viruses are the main causes of acute respiratory infections with the potential to cause pandemics [9–12].
Notably, most emerging viral agents of acute respiratory diseases are of zoonotic origin and pose a
major threat to human health [10–13]. The ongoing coronavirus disease 2019 (COVID-19) pandemic
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exemplifies problems
resulting from emerging zoonotic pathogens [9]. Individuals with frequent and sustained contact
with animals are considered at higher risks of infections with zoonotic pathogens and are therefore
suitable targets for emerging virus surveillance programs [13]. The early detection of emerging viral
pathogens of animal origin that exhibit potential for human-to-human transmission remains a difficult
but essential step to mitigate their propagation.
Here, we characterized the eukaryotic virome of respiratory specimens taken from patients
presenting with acute respiratory infections in a cohort with a high level of animal exposure [14] in
southern Vietnam. Additionally, we compared viral detection by mNGS versus PCR to assess the
utility of mNGS in routine diagnostics.
2. Materials and Methods
2.1. Ethical Approvals
All study subjects gave their informed consent for inclusion before participating in the study.
The study was approved by the Oxford Tropical Research Ethics Committee (OxTREC) (No. 157-12),
the United Kingdom, and the Ethic Committees of Dong Thap Hospital in Dong Thap provinces, Vietnam.
2.2. The Sentinel Cohort Study and Samples
The clinical samples used in this study were derived from a sentinel cohort study described
previously [5,14]. The cohort study is a community-based component of The Vietnamese Initiative
on Zoonotic Infections (VIZIONS) project [15,16], which was conducted to detect potential zoonotic
transmission. In brief, individuals, including animal-raising farmers, slaughterers, animal health
workers, and rat-traders from Dong Thap and Dak Lak provinces in Vietnam, were recruited in the
cohort study and followed for 3 years, 2013 to 2016 [14].
Starting each study year, to create baseline data, the cohort members were interviewed and
them plus their animals (all without symptoms and sign of respiratory disease) were sampled.
During the follow-up period, whenever the cohort member got any signs/symptoms of respiratory
tract infections and fever (≥38 ◦C), specimens from the diseased individual and their animals were
collected. The clinical specimens collected from each cohort member and their animals consisted
of rectal, pooled nasal and throat swabs, and blood [5,14]. Here, we focused on nasal-throat swabs
sampled at respiratory disease episodes during 2013 (Figure 1).
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1. Overview of the methods and main results. HRSC: high risk s ntinel cohort. * see [5],
the 15 v ruses include human rhinovirus (HRV), enteroviru (EVs), coronavirus (CoV) subtype OC43
and NL63, respi atory s ncytial virus (RSV) A, RSV B, human metapneumovirus (MPV), influenza
influenza B virus, adenovirus, parainfluenza virus (PIV)1–4, human bocavirus, and parechovirus.
2.3. Metagenomic Next-Generation Sequencing (MNGs) Assay
Initially, 200 µ of nasal-throat swabs collected at disease episodes and a negative control containing
viral transport medium were first treated with 20 U of turbo DNase (Ambion, Life Technology, Carlsbad,
CA, USA) and 50 U of RNase I (Ambion) at 37 ◦C for 30 min [17]. Viral RNA was then isolated
from nuclease-treated materials using a QIAamp 96 Virus QIAcube HT Kit (QIAGEN GmbH, Hilden,
Germany), following the manufacturer’s instructions for nucleic acid extraction. The nucleic acid
output was then recovered in 50 µL of elution buffer (provided with the QIAamp kit).
Double-stranded DNA synthesis, random amplification, and library preparation were carried out
as previously described [6]. The prepared library was sequenced using the MiSeq reagent kit V3 in an
Illumina MiSeq platform (Illumina, San Diego, CA, USA. The double indexes of Nextera XT Index Kit
(Illumina) was used to multiplex and differentiate the samples in each run.
2.4. Analysis of mNGS Sequence Data
An in-house analysis pipeline was used to analyze sequence data that is posted in GitHub:
https://github.com/xutaodeng/virushunter/. Briefly, the adaptors, low-quality reads, and duplicate
reads were firstly removed. The reads related to human and bacterial genomes were subtracted by
mapping reads using bowtie2 (version 2.2.4) to concatenated human reference genome sequence
and mRNA sequences (hg38), and bacterial nucleotide sequences extracted from NCBI nt fasta file
(ftp://ftp.ncbi.nlm.nih.gov/blast/db/FASTA/, February 2019) based on NCBI taxonomy (ftp://ftp.ncbi.
nih.gov/pub/taxonomy, February 2019) [18]. The remaining reads were de novo assembled using
ENSEMBLE software [19], which uses a partitioned subassembly approach to integrate the use of
various de Bruijn graph (DBG) and overlap-layout-consensus assemblers (OLC) [19]. To allow for
sensitive screening of viral sequences, the resulting contigs (plus single reads) were aligned against
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the viral proteome of the NCBI’s RefSeq and the viral proteome of the non-redundant database by
the Basic Local Alignment Search Tool (BLASTx). Matches with E score <0.01 were retained. To filter
out tentative viral hits that showed better alignments to non-viral sequences, these tentative matches
to viral proteins were then aligned to the GenBank’s entire non-redundant proteome database using
DIAMOND algorithm version 0.9.6 [20]. Sequences were then classified as viral or removed as non-viral
according to the NCBI taxonomy of the best hits (lowest E score) in the non-redundant proteome
database. Viral reads described here have E scores to viral proteins <10−10.
2.5. PCR Confirmatory Testing of Viruses Detected by Metagenomics and Genome Sequencing
mNGS-detected viruses that were previously reported in human samples were confirmed by
specific RT-PCR using previously published or newly designed primers/probes, followed by Sanger
sequencing of the obtained amplicons (if applicable). The PCR confirmatory experiments were carried
out on newly extracted nucleic acid from original patient samples using MagNApure 96 platform
(Roche Diagnostics, Mannheim, Germany) [5]. Inverse primers were used to amplify and then sequence
complete circular virus genomes.
2.6. PCR Screening by New Primers Designed Based on mNGS Contigs
For eukaryotic viral genomes detected in mNGS output, PCRs (confirmed by Sanger sequencing)
were applied to screen for their genetic sequences. The primers were designed based on the
mNGS contigs of the viruses of interest and PCRs conducted on mNGS-negative samples (Figure 1).
PCR screening was carried out on the nucleic acid re-isolated from the original respiratory sample
using a MagNApure 96 platform (Roche Diagnostics) [5].
2.7. Viral Genotyping
Sequences related to the enterovirus genome were classified using the Enterovirus Genotyping
Tool Version 1.0 [21]. For influenza virus A, coronavirus (CoV), and respiratory syncytial virus (RSV)-A,
the read sequences for subtyping [22–24] were located and extracted from mNGS output using the
Map-to-reference tool of Geneious Prime 2020.0.2 software (Biomatters, Auckland, New Zealand).
The recovered sequences were then used to compare against the NCBI non-redundant protein sequence
database using BLASTx (E value ≤10−5).
2.8. Phylogenetic Analysis
Sequence alignment was conducted by the MUSCLE algorithm of MEGA software version X.
Phylogenetic trees were built by the Maximum Likelihood (bootstrap 1000) algorithm of the MEGA.
2.9. Nucleotide Sequence Accession Numbers
The raw NGS reads were deposited in the database of Genbank (PRJNA639353). The GenBank
accession numbers for the novel viral genomes described here are MT649483 and MT649484 (novel
statovirus), MT649485 (novel cyclovirus), and MT649486 (novel gemycircularvirus).
2.10. Statistics
Pearson’s Chi-squared test or Fisher exact test or t-test was applied in the calculation of associations
or differences between variables by pairwise comparisons. The p values were adjusted for multiple
comparisons using the Benjamini and Hochberg method [25] with a false discovery rate (FDR)
calculator [26]. A p ≤ 0.05 was considered significant. The Wilson method in EpiTools [27] was used
to calculate 95% confidence intervals. Pearson’s correlation coefficients were calculated by STATA
software 12.0 to measure the correlation of normally distributed variables. The normality was tested
with normal Q-Q plots by STATA.
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3. Results
3.1. Characteristics of the Cohort Members and Clinical Samples
We first applied mNGS to nasal-throat swab samples collected during disease episodes in 2013.
These samples consisted of 94 samples from 94 disease episodes from 60 study participants residing in
Dong Thap province. A convenience sample size of 91 samples from 58 individuals was selected from
these 94 samples of 60 participants for metagenomics analysis. Of these, 15 were positive for at least
one respiratory viral pathogen and were included as positive controls for mNGS analysis alongside the
remaining 76 RT-PCR negative swabs. The demographic and baseline characteristics of the participants
are presented in Table 1.
Table 1. General characteristics of the 58 cohort members, and comparison between clinical symptoms
recorded at respiratory-disease episodes of PCR-positive and -negative individuals.
mNGS Analysis
Total PCR Positive PCR Negative p Value # ˆ
No. of cohort members N = 58 N = 14 N = 51
Median age (range) (in years) 35.5 (7–76) 31 (13–58) 38 (7–76) 0.465 ##
Sex ratio (male/female) 2.6 (42/16) 1.3 (8/6) 3.3 (39/12) 0.465
Occupations
Animal health worker 12 (20.7) 2 (14.3) 11 (21.6) 1
Animal-raising farmer 26 (44.8) 6 (42.9) 22 (43.1) 1
Slaughterer 18 (31.0) 5 (35.7) 17 (33.3) 1
Rat-trader 2 (3.4) 1 (7.1) 1 (2.0) 0.829
Having chronic diseases 4 (6.9) 0 4 (7.8) 1
Respiratory disease episodes N = 91 N = 15 N = 76
Frequency of clinical signs
Fever 91 (100) 15 (100) 76 (100) -
Cough 75 (82.4) 8 (53.3) 67 (88.2) 0.015
Sneezing 69 (75.8) 14 (93.3) 55 (72.4) 0.465
Sore throat 49 (53.8) 8 (53.3) 41 (53.9) 1
Dyspnea 9 (9.9) 1 (6.7) 8 (10.5) 1
Headache 57 (62.6) 12 (80) 45 (59.2) 0.465
Body aches 47 (51.6) 7 (46.7) 40 (52.6) 1
Watery diarrhea 11 (12.1) 0 (0) 11 (14.5) 0.5
Nausea 2 (2.2) 0 (0) 2 (2.6) 1
The value shows in format of number (percentage). # between PCR-positive vs. PCR-negative columns conducted
by Pearson’s Chi-squared test or Fisher exact test. ## by t-test. ˆ the p values of multiple comparisons were corrected
by the Benjamini and Hochberg method for false discovery rate (FDR) correction.
3.2. Overview of Sequences Detected by Metagenomics
A total of 31,783,202 raw reads were obtained, with a median read of 342,524 and range of
43,930–718,762 reads/sample. Most of the reads were ~145–150bp length. Reads belonged to viral,
bacterial, and human as well as unclassifiable sequences. We focused on viral reads from eukaryotic
viruses, which in total accounted for 2.3% (range: 0.5–12.7%) of the total reads obtained from
individual samples.
Evidence of the sequences related to 52 viral species from 31 families (including 19 viral species
from 13 families that have previously been reported in human samples) was found in 27 of 91 (29.7%,
95% confidence interval (CI): 21.3–39.7%) samples but not in the negative control. After confirmatory
PCR for a subset of viruses, the presence of 12 virus species from 9 families could be confirmed in 22 of
91 samples (24.2%, 95% CI: 16.5–33.9%) (Tables 2 and 3).
Sequences related to those of viruses of invertebrates, plants, fungi, algae, and bacteria were also
detected (Supplementary Table S4).
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Table 2. Detection of respiratory viral pathogens of mNGS in 15 RT-PCR-positive samples where
human viral pathogens were previously detected by diagnostic RT-PCR [5]. HRV: human rhinovirus,
EVs: enterovirus, CoV: coronavirus subtype OC43 and NL63, RSV: respiratory syncytial virus, MPV:
human metapneumovirus.
No. Sample
ID
Multiplex
RT-PCR ** NGS Analysis
Virus
Detected
Ct
Value Virus Genotype Reads (%)
#
Total
Length
(bp)
Genome
Coverage
(%)
Other Virus
Detected ##
1 72
EVs 32.4 Coxsackievirus A21 52,989 (12) 7440 100.0
HRV 37.1 HRV C56 2506 (0.6) 7099 98.1
2 75 EVs 38.6 HRV B 4 (0.0) 598 8.3
3 5 HRV 38.4 HRV B3 678 (0.7) 5512 75.0 Humanbetaherpesvirus 7
4 33 HRV 40 EVs-D68 3174 (0.7) 5629 76.2
5 54 HRV 40 HRV B 6 (0.0) 723 10.0
6 73 HRV 40 HRV B86 6644 (1.5) 7212 99.2 Vientovirus
7 83 HRV 38.7 HRV B79 6157 (1.8) 5639 78.2
Novel
gemycircularvirus
(GemyCV-VZ13)
8 86 HRV 38.2 HRV B79 19,606 (5.6) 7224 99.7
9 91 HRV 40 HRV A57 2538 (1.1) 3450 47.8
10 92 HRV 36.5 HRV B35 12,481 (3.1) 7298 100.0 Bat badicivirus, batposalivirus
11 4 InfluenzaA virus 29.3 Influenza A/N2 virus 2 (0.0) 115 0.8
12 6 CoV * 36 CoV OC43 8 (0.0) 733 2.4
13 52 RSV-A 30.8 RSV-A genotype ON1 236 (0.1) 5398 35.4
14 39 RSV-A 36.3 Not detected 0 0 0
15 65 MPV 39.5 Not detected 0 0 0
* OC43 or/and NL63. ** reported previously [5]. # Total reads of the targeted virus (percentage: the total reads of the
virus per total raw reads of the sample). ## detail of the viruses in Table 3.
Table 3. Metagenomic detection of viruses that have previously been detected in human samples in
nasal-throat swab samples negative for human viral pathogens by diagnostic RT-PCR [5].
No. SampleID
Detected Viruses
Previously Reported in
Human Samples
Confirmed
by PCR
No. of
Reads
Total
Contig
Length
(bp)
Amino Acid
Identity to
GenBank
Strain (%)
Genome
Coverage
(%)
1 89 Rotavirus Yes 17 360 98 1.9
2 73 Vientovirus *# Yes 2 146 53 4.8
3 23 Novel cyclovirus(CyCV-VZ13) Yes 5 448 61.8 25.9
4 32 Novel gemycircularvirusvirus (GemyCV-VZ13) Yes 1852 1995 39 91
5 83 GemyCV-VZ13 Yes 120 2000 45 92
6 89 GemyCV-VZ13 Yes 1 148 46.9 6.8
7 24 Novel statovirus(StatoV-VZ13) Yes 91 1018 42.5 24.6
8 32 StatoV-VZ13 Yes 5 231 35 5.6
9 82 StatoV-VZ13 Yes 27 2000 49 48.4
10 87 Gemycircularvirus Yes 39 858 83 39
11 71 Gemycircularvirus Yes 117 1400 97 63.7
12 88 Gemycircularvirus Yes 2 300 73 13.6
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Table 3. Cont.
No. SampleID
Detected Viruses
Previously Reported in
Human Samples
Confirmed
by PCR
No. of
Reads
Total
Contig
Length
(bp)
Amino Acid
Identity to
GenBank
Strain (%)
Genome
Coverage
(%)
13 11 Statovirus Yes 4 351 91 8.5
14 71 Statovirus Yes 7 812 90 19.6
15 5 Human betaherpesvirus 7 * Not done 2 295 100 0.2
16 15 Human papillomavirus Not done 73 1280 99.3 17.5
17 17 Human papillomavirus Not done 6 437 97.9 6
18 2 Torque teno virus Not done 4 554 88.4 14.6
19 68 Torque teno virus Not done 2 217 70.6 5.7
20 24 MPV No 6 417 100 3.1
21 47 RSV A No 6 468 100 3.1
22 92 Bat badicivirus-like virus * No 2 204 49 2.3
23 92 Bat posalivirus-like virus * No 3 182 56 2
24 83 Viruses of Circoviridaefamily No 10 167 64 7
* Co-detected with other viral pathogens in 15 positive-control samples as reported in Table 2. # will be described in
a separate paper.
3.3. Viral Detection in Positive Controls
Sequences related to 5 viral pathogens detected by diagnostic RT-PCRs were detected by mNGS in
13 of 15 (86.7%, 95% CI: 62.1–96.3%) samples, including 8 human rhinovirus (HRV), 1 enterovirus (EVs),
1 mix-detection of HRV and EVs, 1 influenza A virus, 1 coronavirus (CoV), and 1 respiratory syncytial
virus (RSV) A. mNGS failed to detect RSV (cycle threshold (Ct): 36.3) and human metapneumovirus
(MPV) (Ct: 40) in 2/15 RT-PCR-positive samples (Table 2) but detected in only 2 other samples,
which were negative in RT-PCR (Table 3).
Using the mNGS sequences, the viruses detected in 13/15 patients by diagnostic RT-PCRs were
successfully genotyped (Table 2). Based on mNGS sequences, cross-detection between EVs and HRV
by RT-PCRs in two samples was detected and corrected to HRV-B and EV-D68, respectively (Table 2),
and generated (almost) complete genomes (≥75% coverage) of HRV (n = 6) and EVs (n = 2) (Table 2).
Phylogenetic analysis of the six HRV sequences revealed that they belong to species B (n = 4), species A
(n = 1) and species C (n = 1) (Supplementary Figure S1).
3.4. Viral Detection in RT-PCR-Negative Swabs and Results of Confirmatory PCR
Of the 76 RT-PCR-negative samples, sequences related to 12 viral species of 9 families that
have previously been reported in both sterile and non-sterile human samples were found in 16 of 76
(21.1%) samples. They included both known human viruses (rotavirus, MPV, RSV, torque teno virus,
human papillomavirus) and other viruses whose tropism is still unknown (novel cyclovirus, novel
gemycircularvirus, novel statovirus, viruses of the Circoviridae family, gemycircularvirus, and statovirus)
(Table 3).
In the 15 control samples where human viral pathogens were previously detected by diagnostic
RT-PCR, we also detected by mNGS the following viruses: human betaherpesvirus 7, vientovirus,
gemycircularvirus, bat badicivirus-like virus [28], and bat posalivirus-like virus [28] in 4 of 15 (26.7%)
samples (Tables 2 and 3).
Using specific PCR, we were able to confirm the presence of rotavirus (n = 1), novel cyclovirus
(n = 1), novel gemycircularvirus (n = 3), novel statovirus n = 3), gemycircularvirus (n = 3), statovirus
(n = 2), and vientovirus (n = 1) (Table 3) in 10 samples (8 of 76 (10.5%) RT-PCR-negative and 2 of 15
(13.3%) RT-PCR-positive samples).
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3.5. Detection and Genomic Characterization of Novel Viruses
3.5.1. A Novel Cyclovirus
Two cyclovirus-related contigs were generated from the NGS output of a single sample of acute
respiratory disease with an unknown (diagnostic RT-PCR negative) etiology. A complete circular
DNA genome of 1740 bp was then obtained by inverse PCR and Sanger sequencing (Supplementary
Table S1). The complete genome shared the highest nucleotide identity (55%) to cyclovirus NG 14
(accession number: NC_038417), which is lower than the species demarcation threshold (80% identity
of the genome-wide nucleotide sequence) [29]. Phylogenetic analysis of capsid and rep proteins,
216 and 279 amino acids long, respectively, confirmed its genetic distinction from other cycloviruses
(Figure 2), suggesting that it is a novel cyclovirus species, tentatively named Cyclovirus VIZIONS-2013
(CyCV-VZ13).
Besides being detected in 1 of 91 samples by mNGS analysis, subsequent PCR screening with
primers based on mNGS contigs detected the CyCV-VZ13 genome in 5 of the 90 mNGS-negative
samples (5.6%). Mix detections with other viruses were found in several samples (Supplementary
Tables S2 and S3).
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gemycircularvirus is a 78% genome-wide pairwise identity [30]. All of the proposed species (n = 43; 
73 strains) within the genus Gemycircularvirus share 56–77% whole-genome similarity with each other 
[30]. These suggest that a member of a novel gemycircularvirus species was discovered, which we 
tentatively named gemycircularvirus VIZIONS-2013 (GemyCV-VZ13). The phylogenetic analyses of 
the capsid (298 amino acid) and replication proteins (333 amino acid) were in agreement with this 
suggestion (Figure 3).  
Figure 2. Phylogenetic tree of capsid (A) and replication (B) protein of Cyclovirus VIZIONS-2013
(CyCV-VZ13) compared to known viruses of the Circoviridae family.
3.5.2. A Novel Gemycircularvirus
Multiple gemycircularvirus-related contigs were detected in the mNGS output of a single
sample of acute respiratory disease with a RT-PCR-unknown etiology. Based on PCR with inverse
primers (Supplementary Table S1), and Sanger sequencing, a complete circular DNA genome of
2171 bp was generated. The complete genome shared the highest nucleotide identity (48.3%) to a
murine feces-associated gemycircularvirus 2 (GenBank: MF416388.1). The species demarcation of
gemycircularvirus is a 78% genome-wide pairwise identity [30]. All of the proposed species (n = 43;
73 strains) within the genus Gemycircularvirus share 56–77% whole-genome similarity with each
other [30]. These suggest that a member of a novel gemycircularvirus species was discovered, which we
tentatively named gemycircularvirus VIZIONS-2013 (GemyCV-VZ13). The phylogenetic analyses of
the capsid (298 amino acid) and replication proteins (333 amino acid) were in agreement with this
suggestion (Figure 3).
The sequences of GemyCV-VZ13 were found in the mNGS output and confirmed by PCR of
two more samples. Besides being detected in 3 of 91 samples in the mNGS analysis, subsequent
PCR screeni g yielded evidence of GemyCV-VZ13 in 12 of 88 (13.6%) mNGS-negative samples.
Mix d tections with other virus s were also found (Supplementary Tables S2 and S3).
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3.5.3. A Novel Statovirus
Seven statovirus-related contigs were detected in mNGS output from three nasal-throat swab
samples with negative diagnostic RT-PCR. Subsequently, partial RNA-dependent RNA polymerase
(RdRp) and coat protein sequences were generated with 249 and 260 amino acids in length,
respect vely, sharing 40.4% and 45% amino acid identity with vailable statoviruses sequences.
Currently, no species/genus demarcation of statoviruses is available [31]; however, based on the low
identity of the RdRp protein sequence with other statoviruses and the distinction in the phylogenetic tree
(Figure 4), we proposed this as a novel statovirus species, tentatively named statovirus VIZIONS-2013
(StatoV-VZ13).
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Thus, StatoV-VZ13 was detected in 3/91 (3.3%) samples collected at disease episodes.
4. Discussion
We describe here viral nucleic acids in nasal-throat swab samples from cases of acute respiratory
diseases of unknown etiology from people at risk of zoonotic infections from Dong Thap province of
Vietnam in 2013. We identified 12 species from 9 families of viruses that have previously been reported
in various human samples. Sequences related to bacterial viruses, invertebrate viruses, fungal viruses,
insect viruses, plant viruses, and algae viruses were also detected in the samples. Therefore, this viral
survey expands our understanding of virus populations in acute respiratory diseases, particularly in
people at risk of zoonotic infections, in Vietnam.
Metagenomic detection of most respiratory viral pathogens detected by RT-PCR indicated that the
mNGS pipeline/protocol applied here is a sensitive pan-pathogen assay of respiratory viral pathogens
in clinical samples, in agreement with previous studies [6,17,32]. Only sequences of RSV A and
MPV were not detected from metagenomic output in the two diagnostic RT-PCR positive samples
(RSV A- and MPV-PCR-positive samples) but were instead identified in only two other samples,
suggesting that index-hopping probably happened, although contamination or pipette mistakes were
not excluded. Additionally, detecting and correcting cross-reactivity between EVs and HRV in RT-PCR
results, and genotyping other strains highlights one of the advantages of metagenomics in etiological
and epidemiological studies compared to RT-PCR. Indeed, the analysis of HRV based on the obtained
sequences suggested the predominance of HRV B in acute respiratory diseases in adults and imported
HRV into Vietnam from several independent events. Notably, few studies reported the genetic diversity
of HRV circulating in Vietnam. As such, our data has also shed light on the diversity of HRV in
this locality.
The detection of several novel or recently identified viral genomes, including CyCV-VZ13,
GemyCV-VZ13, StatoV-VZ13, and vientovirus, show that metagenomics is suitable as a sensitive
pan-pathogen assay for sequence-independent detections of a variety of viruses, including novel ones.
However, more frequent detections of the novel viruses by PCR than by metagenomics on the same
samples suggests that PCR currently remains the most sensitive test for the diagnosis of those viruses
whose genomes are already known. The main advantages of metagenomics are therefore the ability to
detect and sequence all viral genomes simultaneously rather than perform an extensive set of different
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RT-PCRs. Currently, there are no robust criteria that can reliably define a true positive metagenomic
result without the requirement of conducting confirmatory experiments [8,33]. As an exploratory study,
we pragmatically took into account short viral reads presenting in the tested samples at any frequency
for subsequent confirmatory PCR testing. This led to the discovery of several new viruses (CyCV-VZ13,
StatoV-VZ13, and GemyCV-VZ13) in the present study, and the correct detection of influenza A virus
in an RT-PCR-positive nasal-throat swab. Of note, a novel cyclovirus has previously been discovered
and characterized based on a single initial read [34]. Collectively, the data thus suggest that even a
single or a few viral reads generated by metagenomics can be a reliable marker for pathogen detection
and discovery provided that the sequence similarity is high enough or used as an initial step towards
generating a longer contig.
Cycloviruses belong to the Circoviridae family The closely related circoviruses are well known
as pathogens in swine and birds and several other animals [35,36]. The natural hosts and
pathogenic potentials of members of the Cyclovirus genus have not been definitely determined [36].
However, cyclovirus sequences have been detected in blood [37], cerebrospinal fluid [34,38],
human respiratory tract [34,39], and persistent detection of identical sequences in the serum of
immunodeficient patients [40]. Similarly, whether gemycircularviruses can infect humans is unknown.
The germycircularvirus genome was identified in a wide range of host, in the feces of different animals,
plants, insects, sewage, in the human respiratory tract [41], in blood from a patient with multiple
sclerosis, and in the cerebrospinal fluid of encephalitis patients [41–45]. Statoviruses belong to a
novel taxon of RNA viruses and have been detected in stool samples of diverse mammals, including
human, macaque, mouse, and cow, but not in public sequencing datasets from bacteria, fungi, plants,
unicellular eukaryotic organisms, or environmental samples and in the human respiratory tract [31].
The identification of novel viruses, including CyCV-VZ13, GemyCV-VZ13, and StatoV-VZ13, contributes
to a better understanding of the respiratory virome in this part of the world. However, sequences
related to viruses of the phylum Cressdnaviricota are ubiquitous contaminants of commonly used
metagenomic reagents [46,47]. Thus, whether these genomes infect human cells, other non-human
cells in the lungs, or reflect passive contamination of the respiratory tract will require further studies.
5. Conclusions
Our study demonstrates the presence of known and novel viruses in patients with acute
respiratory diseases at risk of zoonotic infections. mNGS is a sensitive pan-pathogen assay for
sequence-independent detection of respiratory viral pathogens in clinical samples. The detection
of several novel viruses further contributes to our understanding of the human respiratory virome,
and warrants further research to ascribe the clinical significant potential of these novel viruses.
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